Hospital M&A Hits Six-Year High in Q1 2026 as Systems Reposition Ahead of Policy Shifts
Hospital M&A hit a six-year high in Q1 2026 with 22 newly announced transactions carrying combined transacted revenue of $14.5 billion — the highest Kaufman Hall has recorded since tracking began in 2018. More than two-thirds of deals involved a divestiture, and for-profit systems participated as buyers in six deals versus just one across all of 2025. Three mega-mergers drove average deal size, including the proposed Sutter Health–Allina Health combination. Kaufman Hall analysts cite anticipatory repositioning ahead of the One Big Beautiful Bill Act’s Medicaid cuts as a key driver, with independent systems seeking scale before reimbursement headwinds arrive in 2027. Underlying hospital finances remain tight: the calendar YTD operating margin index fell to 1.9% in February 2026, down from 3.7% at year-end 2025, with total daily expenses running 6% above prior year while revenue grew only 4%.
For PE sponsors, DSO operators, and health system strategists, this is the clearest signal yet that the consolidation window is reopening — and that deal motivations have shifted from growth optimization to defensive repositioning. Understanding which systems are divesting and why is essential intelligence for any operator planning M&A activity in the next 12–18 months.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.